Molecular diagnostics market global industry analysis, size, share, growth, trends and forecast, 2013 – 2019

Transparency Market
Research
Molecular Diagnostics
Market- Global Industry
Analysis, Size, Share,
Growth, Trends and
Forecast, 2013 – 2019
Single User License:
USD 4595
Multi User License:
USD 7595
Corporate User License:
USD 10595
Molecular Diagnostics Market Expected to Reach USD 8.7
Billion Globally in 2019: Transparency Market Research
Transparency Market Research
State Tower,
90, State Street, Suite 700.
Albany, NY 12207
United States
www.transparencymarketresearch.com
sales@transparencymarketresearch.com
122 Page ReportPublished Date
6-Feb-2014
Request SampleBuy Now
Press Release

According to a new market report published by Transparency Market Research "Molecular Diagnostics
Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology
testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,
2013 - 2019," the global molecular diagnostics market was valued at USD 4.3 billion in 2012 and is
expected to grow at a CAGR of 11.1 % from 2013 to 2019, to reach an estimated value of USD 8.7
billion in 2019.
Browse Molecular Diagnostics Market Report with Full TOC at
http://www.transparencymarketresearch.com/molecular-diagnostics-industry.html
Molecular diagnostics is defined as a class of diagnostic tests that identifies proteins or nucleic acid at
a molecular level. This class of test assists in identification of genetic markers of patient or nucleic
acids in foreign organism. Currently, molecular diagnostics forms relatively a small portion of the
overall diagnostics market but is identified as the fastest growing sector. The growth of this segment
is being supported by rapid turnaround time, low cost, convenient workflow and high sensitivity.
Moreover, growth of this segment is fuelled by rising incidence of chronic disorders, increasing
geriatric population and adoption of personalized medicines. Molecular diagnostics test is rapidly
being developed for genetic testing, infectious diseases testing, blood screening, oncology testing,
cardiovascular testing and others.
Get Free Sample Report at http://www.transparencymarketresearch.com/sample/sample.php?
flag=S&rep_id=1783
Molecular diagnostics is rapidly an evolving market supported by increasing R&D activities for
biomarker identification coupled with emergence of new applications of these tests. Infectious disease
alone captures 60% share of the total molecular diagnostics applications market and remaining one
third is attributed to genetic testing and blood donor screening. The growth of this segment is driven
by rising incidence of cervical cancer caused due to Human Papilloma Virus (HPV). HPV is known to be
a causative agent for cervical cancers hence HPV testing is projected to have a CAGR of 14.8% during
the forecast period of 2013-2019. Hospital acquired infections (HAI)is anticipated as the fastest
growing segment within infectious diseases and is expected to show CAGR of 15.1% from 2013-2019.
Oncology testing and HLA typing testing are also projected to grow at a rapid rate during the same
forecast period.
Technology wise, PCR accounts for the largest share followed by Transcription Mediated Amplification
(TMA), with these two technologies accounting for nearly 50% of the share of molecular diagnostics
market. Next generation sequencing is expected to witness the highest growth rate in the near future.
High sensitivity, reliability and rapid turnaround time are some of the factors that are expected to
trigger market growth. Microarray and hybridization techniques are also expected to show moderate
growth. However, issues with reimbursement policies and strict regulatory requirements are some
factors, expected to hinder the growth of molecular diagnostics market.
Browse all Medical Devices Market Research Reports @
http://www.transparencymarketresearch.com/medical-devices-market-reports-6.html
REPORT DESCRIPTION

Geographically, North America and Europe comprises majority of the molecular diagnostics market
share. Increasing investments in genomics and proteomics, rising awareness and acceptance of
personalized medicines along with increasing incidence of chronic diseases are some of the factors
that have driven the molecular diagnostics industry in these regions. However, Asia-Pacific is
projected to witness fastest growth rate during the forecast period, reporting a CAGR of more than
14%. Economic developments and rising patient awareness towards wellness, preventive medicine
and access to technologically advanced products are some of the key growth factors in this region.
Additionally, growth in this market is fuelled by spread of infectious diseases such as H1N1, HIV, rise
in aging population, and robust government support.
Molecular diagnostics market is highly fragmented comprising small and large vendors. Roche
Diagnostics is expected to lead the market owing to its extensive product portfolio in the molecular
diagnostics segment. Other players of this market include Novartis Diagnostics, Abbott Laboratories,
Qiagen, Hologic Gen-Probe, among others.
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Assumptions
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Molecular Diagnostics Market (2012 & 2019)
2.2 Global Molecular Diagnostics Market, by Technology, 2012 (USD Million)
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
TABLE OF CONTENT

3.2.1 Rising incidence of cancer cases
3.2.2 Aging population
3.2.3 Increase in incidence of chronic diseases
3.2.4 Increasing awareness and acceptance of companion diagnostics and personalized medicines
3.3 Market Restraints
3.3.1 Issues with reimbursement policies
3.4 Market Opportunities
3.4.1 Technological advancements
3.4.2 Tapping the emerging economies
3.5 Porter’s Five Force Analysis: Global Molecular Diagnostics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of the Global Molecular Diagnostics Market, by Geography
Chapter 4 Molecular Diagnostics Market, by Technology
4.1 Overview
4.1.1 Global Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)

4.2 Polymerase Chain Reaction (PCR)
4.2.1 Global PCR Market, 2011 – 2019 (USD Million)
4.3 Transcription Mediated Amplification (TMA)
4.3.1 Global TMA Market, 2011 – 2019 (USD Million)
4.4 Microarray
4.4.1 Global Microarray Market, 2011 – 2019 (USD Million)
4.5 Hybridization (ISH and FISH)
4.5.1 Global Hybridization Market, 2011 – 2019 (USD Million)
4.6 Next-generation sequencing
4.6.1 Global Next generation sequencing Market, 2011 – 2019 (USD Million)
4.7 Others
4.7.1 Global Others Market, 2011 – 2019 (USD Million)
Chapter 5 Global Molecular Diagnostics Market, by Applications
5.1 Overview
5.1.1 Global Molecular Diagnostics Market, by Applications, 2011 – 2019 (USD Million)
5.2 Infectious Diseases
5.2.1 Global Infectious Diseases Market, by Segments, 2011 – 2019 (USD Million)
5.2.2 Virology
5.2.2.1 Global Virology Market, by Segments, 2011 – 2019 (USD Million)
5.2.2.2 Human immunodeficiency virus (HIV) testing
5.2.2.2.1 Global HIV testing Market, 2011 – 2019 (USD Million)
5.2.2.3 Human papillomavirus (HPV) testing

5.2.2.3.1 Global HPV testing Market, 2011 – 2019 (USD
Million)
5.2.2.4 Hepatitis C virus (HCV) testing
5.2.2.4.1 Global HCV testing Market, 2011 – 2019 (USD Million)
5.2.2.5 Others
5.2.2.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
5.2.3 Bacteriology
5.2.3.1 Global Bacteriology Market, by Segments, 2011 – 2019 (USD Million)
5.2.3.2 Hospital Acquired Infection (HAI) testing
5.2.3.2.1 Global HAI testing Market, 2011 – 2019 (USD Million)
5.2.3.3 Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing
5.2.3.3.1 Global CT/NG testing Market, 2011 – 2019 (USD Million)
5.2.3.4 Others
5.2.3.4.1 Global Others testing Market, 2011 – 2019 (USD Million)
5.3 Genomics
5.3.1 Global Genomics Market, by Segments, 2011 – 2019 (USD Million)
5.3.2 Genetic testing for inherited disorders
5.3.2.1 Global Genetic testing for inherited disorders Market, 2011 – 2019 (USD Million)
5.3.3 Human Leukocyte Antigen (HLA)testing
5.3.3.1 Global HLA testing Market, 2011 – 2019 (USD Million)
5.3.4 Pharmacogenetics testing
5.3.4.1 Global Pharmacogenetics testing Market, 2011 – 2019 (USD Million)
5.3.5 Oncology testing
5.3.5.1 Global Oncology testing Market, 2011 – 2019 (USD Million)

5.4 Blood Donor Screening
5.4.1 Global Blood donor screening testing Market, 2011 – 2019 (USD Million)
5.5 Others
5.5.1 Global Others testing Market, 2011 – 2019 (USD Million)
Chapter 6 Global Molecular Diagnostics Market, by Geography
6.1 Overview
6.1.1 Global Molecular Diagnostics Market, by Geography, 2011 – 2019 (USD Million)
6.2 Comparative Analysis: Molecular Diagnostics Market, by Geography, 2012 & 2019 (Value %)
6.3 North America
6.3.1 North America Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.3.2 North America Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.4 Europe
6.4.1 Europe Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.4.2 Europe Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.5 Asia-Pacific
6.5.1 Asia Pacific Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.5.2 Asia-Pacific Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)
6.6 RoW
6.6.1 RoW Molecular Diagnostics Market, by Application, 2011 – 2019 (USD Million)
6.6.2 RoW Molecular Diagnostics Market, by Technology, 2011 – 2019 (USD Million)

Chapter 7 Global Molecular Diagnostics Market Share Analysis
7.1 Market Share Analysis by Key Players of Global Molecular Diagnostics Market
7.1.1 Global Molecular Diagnostics Market Share Analysis, by Key Players, 2012 (%)
7.1.2 Competitive Position of Key Players by Segment : Global Molecular Diagnostics Market
Chapter 8 Recommendations
8.1 Market Strategies for Success
8.1.1 Long term contracts with healthcare service providers
8.1.2 Investing in emerging economies such as China, India and Russia
8.1.3 Broadening of distribution network
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Overview
9.1.3 Product Portfolio
9.1.4 Business Strategies
9.1.5 Recent Developments
9.2 Becton Dickinson & Company

9.3 bioMerieux
9.4 Bio-Rad
9.5 Cepheid
9.6 Danaher Corporation (Beckman Coulter)

9.7 F. Hoffmann-La Roche Ltd.
9.8 Hologic, Inc. (Gen-Probe)
9.9 Myriad Genetics, Inc.
9.9.2 Financial Performance

9.10 Novartis International AG
9.11 Qiagen
9.12 Quest Diagnostics, Inc.
9.13 Siemens AG

9.14 Thermo Fisher Scientific
Transparency Market Research is a market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-
looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use
proprietary data sources and various tools and techniques to gather, and analyze information. Our
business offerings represent the latest and the most reliable information indispensable for businesses to
sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Blog: https://tmrresearch.wordpress.com/
About Us

Molecular diagnostics market global industry analysis, size, share, growth, trends and forecast, 2013 – 2019

Recommended

Recommended

More Related Content

Featured

Featured (20)

Molecular diagnostics market global industry analysis, size, share, growth, trends and forecast, 2013 – 2019